Progression of retinopathy during pregnancy in type 1 diabetes mellitus

Rahman, Waheeda; Rahman, Farooq; Yassin, Sanaa A.; Al-Suleiman, Suleiman A.; Jamal, Rahman

doi:10.1111/j.1442-9071.2006.01413.x

Cited by 64 publications

(75 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, long term detrimental effects are rare 63 64. Laser treatment before pregnancy protects against progression in pregnancy and therefore, wherever possible, should be performed before conception 65. When diabetic retinopathy does develop de novo in pregnancy it is usually not severe and laser treatment is safe if required 65 66.…”

Section: Antenatal Carementioning

confidence: 99%

“…Laser treatment before pregnancy protects against progression in pregnancy and therefore, wherever possible, should be performed before conception 65. When diabetic retinopathy does develop de novo in pregnancy it is usually not severe and laser treatment is safe if required 65 66. Good blood pressure and glycaemic control both lessen retinopathy progression 67.…”

Section: Antenatal Carementioning

confidence: 99%

See 1 more Smart Citation

Diabetes in pregnancy: health risks and management

Ali

Dornhorst

2011

Postgraduate Medical Journal

View full text Add to dashboard Cite

Diabetes in pregnancy is increasing and therefore it is important to raise awareness of the associated health risks to the mother, the growing fetus, and the future child. Perinatal mortality and morbidity is increased in diabetic pregnancies through increased stillbirths and congenital malformation rates. These are mainly the result of early fetal exposure to maternal hyperglycaemia. In the mother, pregnancy may lead to worsening or development of diabetic complications such as retinopathy, nephropathy, and hypoglycaemia. This review defines pregestational and gestational diabetes and the associated health risks to the growing fetus and mother. Management is discussed, focusing on clinical evidence based guidelines published by the American Diabetic Association and the UK National Institute for Health and Clinical Excellence on the management of pregnant women with pre-existing diabetes.

show abstract

Section: Antenatal Carementioning

confidence: 99%

Section: Antenatal Carementioning

confidence: 99%

Diabetes in pregnancy: health risks and management

Ali

Dornhorst

2011

Postgraduate Medical Journal

View full text Add to dashboard Cite

show abstract

“…Trends toward substantially improved diabetes control during pregnancy are likely to result in lower blood sugar levels and therefore less concern regarding DR risk. Duration of diabetes greater than 15 years, poor glycaemic control and hypertension were identified as high-risk factors in the progression of DR in pregnancy 312 .…”

Section: Pregnancymentioning

confidence: 99%

A game changer for eye care for diabetes

Taylor

2017

Medical Journal of Australia

View full text Add to dashboard Cite

“…Data were extracted from the abstracts because for the first study we could not get the complete article [12], and for the second study, the article was in the French language but the abstract was in English [13]. Through 45 years (1969Through 45 years ( -2014, most of the studies reported were carried out in Egypt, with 9 studies [14][15][16][17][18][19][20], followed by Saudi Arabia with 5 studies [21][22][23][24][25] (Table 1). The rates of retinopathy among Arab patients with T1D ranged from low in Saudi Arabia [21] to high in Yemen [26] (Table 1).…”

Section: Diabetic Retinopathy In the Arab Countriesmentioning

confidence: 99%

Retinopathy of Type 1 Diabetes in Arab Countries: Systematic Review and Meta-Analysis

et al. 2018

View full text Add to dashboard Cite

Aims: To conduct a systematic review and meta-analysis of retinopathy prevalence in patients with type 1 diabetes (T1D) in 22 Arab countries. Methods: We systematically searched 4 different literature databases (PubMed, Science Direct, Web of Science and Embase), from the date of inception until December 2017, to collect all the information about patients with T1D who developed retinopathy complications; for statistical analysis, we used MetaXL to evaluate the pooled prevalence estimate and the subgroup prevalence estimates employing double arcsine transformation and inverse variance heterogeneity models. Results: Our search strategy returned 475 studies, of which 39 met our inclusion criteria; of those, 16 were eligible for meta-analysis that were captured only in 15 Arab countries, through 45 years (1969–2014). The number of retinopathy patients was 396 out of 1,931 patients with T1D. The prevalence of retinopathy was 19% (95% CI 10–28%). Substantial heterogeneity was observed (Q 240.78, p < 0.0001, I² 93.77%, 95% CI 91.35–95.52%); however, no single study considerably affected the overall pooled prevalence estimate. Conclusion: Almost one fifth of T1D patients in 15 Arab countries have diabetic retinopathy, therefore it is important to improve the care of patients with T1D and in Arab countries to avoid the development of such a devastating complication.

show abstract

Progression of retinopathy during pregnancy in type 1 diabetes mellitus

Cited by 64 publications

References 31 publications

Diabetes in pregnancy: health risks and management

Diabetes in pregnancy: health risks and management

A game changer for eye care for diabetes

Retinopathy of Type 1 Diabetes in Arab Countries: Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About